The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Stress urinary incontinence affects millions of women worldwide and has a profound impact on
the quality of life of older individuals, their subjective health status, levels of
depression and need for care. Midurethral sling placement was introduced in 1995 and remains
the current gold standard for surgical management of SUI. Although the advantages of
midurethral sling surgery include its high success and minimally invasive approach,
approximately 10-50% of women experience acute postoperative urinary retention and are
subsequently sent home with an indwelling foley catheter or clean intermittent self
catheterization. Urinary retention is anxiety provoking for most patients and adds morbidity,
cost, and increased utilization of healthcare resources. Additionally, catheterization of the
urinary tract results in increased risk of urinary tract infection and potential need for
antibiotics.
Several recent studies have reported varying rates of postoperative voiding trial success
depending on the type of local anesthetic used for hydrodissection; however the data is
sparse and invites a more thorough investigation. Furthermore, to the investigators
knowledge, no studies have systematically explored dosage or type of agent used
intraoperatively on postoperative voiding function. Based on the preliminary data, the
investigators hypothesize that patients receiving normal saline compared to a local
anesthetic (e.g., lidocaine) will have a reduction in duration of postoperative urinary
retention following retropubic midurethral sling placement.